RecruitingNCT06791668

Different Regimens of Magnesium Sulphate in Patients With Severe Preeclampsia

Comparison of Different Regimens of Magnesium Sulphate in Patients With Severe Preeclampsia in Ain Shams University Maternity Hospital (Retrospective Cohort)


Sponsor

Ain Shams Maternity Hospital

Enrollment

400 participants

Start Date

Dec 3, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to learn about the effects of the different drug regimens of magnesium sulphate in treatment of (severe pre-eclampsia). This condition affects some pregnant women and raises their blood pressure. It may also cause seizures (fits). The medication (magnesium sulphate) helps to prevent seizures. The main question this study aims to answer is: What are the different regimens of magnesium sulphate that are used to prevent seizures in pregnant women with severe pre-eclampsia? Participants already have taken the magnesium sulphate as part of their regular medical care for severe pre-eclampsia. Researchers will look into the records of the participants in the past 5 years to collect the data.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria1

  • All hospital records of patients diagnosed as preeclampsia with severe features planned to receive magnesium sulphate.

Exclusion Criteria1

  • Records with missing data about the regimen of magnesium sulphate used

Locations(1)

Ain Shams University Maternity Hospital

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06791668


Related Trials